Back to Trades
Patel Naimish
DirectorCIK 0002021679
Total Volume
$3.3M
8 filings
Purchases
$49.7K
1 buy txns
Sales
$362.6K
2 sell txns
Net Activity
-$312.9K
net sold
Profile
- Filings
- 8
- Buy transactions
- 1
- Sell transactions
- 2
- Companies
- 2
- Active
- 2025–2026
Patel Naimish, Director, accounts for 8 disclosed filings worth $3.3M, spread across 2 companies, active 2025–2026. The record is heavily weighted toward selling, with $49.7K in purchases against $362.6K in sales. The largest single open-market purchase on record is $49.7K in CRISPR Therapeutics AG. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Sep 15 | AGMB AgomAb Therapeutics NV | Patel Naimish | Director | Award | $0 |
| Sep 15 | AGMB AgomAb Therapeutics NV | Patel Naimish | Director | Other | $0 |
| Jun 2 | CRSP CRISPR Therapeutics AG | Patel Naimish | Insider | Award | $0 |
| Jun 1 | CRSP CRISPR Therapeutics AG | Patel Naimish | Insider | Sell | $210.6K |
| Mar 24 | CRSP CRISPR Therapeutics AG | Patel Naimish | Insider | Award | $1.8M |
| Mar 17 | CRSP CRISPR Therapeutics AG | Patel Naimish | Insider | Sell | $152.0K |
| Jan 27 | CRSP CRISPR Therapeutics AG | Patel Naimish | Insider | Buy | $49.7K |
| Oct 3 | CRSP CRISPR Therapeutics AG | Patel Naimish | Insider | Award | $1.1M |
8 filings